Descartes-08 — Topline data
1Q27
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis (MG) continues to advance; data expected in 1Q27, biologics license application (BLA) filing planned for mid-2027Source filing
RNAC biotech catalysts & pipeline
CARTESIAN THERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
Descartes-08 — Topline data
1H27
Phase 1/2 HELIOS pediatric trial of Descartes-08 in juvenile dermatomyositis (JDM) continues to progress with data expected in 1H27Source filing
Descartes-08 — NDA/BLA submission
mid-2027
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis (MG) continues to advance; data expected in 1Q27, biologics license application (BLA) filing planned for mid-2027Source filing